Management of Treatment Resistant Depression: The Art and the Science
The purpose of this activity is to improve the clinicians' ability to apply evidence for novel therapies for treatment-resistant depression.
Following participation in this course, participants should be able to:
- Describe the role of atypical antipsychotics in the treatment-resistant depression
- Examine the role of combination pharmacotherapy in treatment-resistant
- Apply evidence for novel therapies for treatment-resistant depression
Charles B. Nemeroff, M.D., Ph.D
Physicians: The University of Nevada, Reno School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Nevada, Reno School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: The University of Nevada, Reno School of Medicine approves this program for 1.00 hour of nursing continuing education credit.
Suicide Prevention: This program provides 1.00 CME credit towards the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to suicide prevention, intervention and detection every 4 years.
- 1.00 AMA PRA Category 1 Credit™
This course is offered through University of Nevada, Reno School of Medicine.
To take this course you will be redirected to University of Nevada, Reno School of Medicine's website. You must login or create an account with University of Nevada, Reno School of Medicine in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!